Should clinical trials about prostate cancer assess the frailty as an endpoint?
- PMID: 37195573
- DOI: 10.1007/s11255-023-03636-8
Should clinical trials about prostate cancer assess the frailty as an endpoint?
Comment on
-
Frailty Assessment for Outcome Prediction of Patients With Prostate Cancer Receiving Radical Prostatectomy: A Meta-Analysis of Cohort Studies.Clin Nurs Res. 2022 Jul;31(6):1136-1147. doi: 10.1177/10547738221100350. Epub 2022 Jun 9. Clin Nurs Res. 2022. PMID: 35684966
References
-
- Boyle HJ, Alibhai S, Decoster L, Efstathiou E, Fizazi K, Mottet N et al (2019) Updated recommendations of the international society of geriatric oncology on prostate cancer management in older patients. Eur J Cancer 116:116–136. https://doi.org/10.1016/J.EJCA.2019.04.031 - DOI - PubMed
-
- Gluszak C, Campion L, Seegers V, Cojocarasu O, Commer JM, Priou F et al (2023) Geriatric assessment ımplementation before chemotherapy in metastatic prostate cancer, results from the real-life study gamers. J Clin Med. https://doi.org/10.3390/jcm12041636 - DOI - PubMed - PMC
-
- Dent E, Martin FC, Bergman H, Woo J, Romero-Ortuno R, Walston JD (2019) Management of frailty: opportunities, challenges, and future directions. Lancet (London, England) 394:1376–1386. https://doi.org/10.1016/S0140-6736(19)31785-4 - DOI - PubMed
-
- Liu X, Sun W (2022) Frailty assessment for outcome prediction of patients with prostate cancer receiving radical prostatectomy: a meta-analysis of cohort studies. Clin Nurs Res 31:1136–1147. https://doi.org/10.1177/10547738221100350 - DOI - PubMed
-
- Pan YY, Meng LC, Chen HM, Chen LK, Hsiao FY (2022) Impact of frailty on survivals of prostate cancer patients treated with radiotherapy. Arch Gerontol Geriatr 100:104651. https://doi.org/10.1016/j.archger.2022.104651 - DOI - PubMed